| CAS Number | 112732-17-9 |
|---|---|
| Molecular Formula | C19H23ClFN3O3 |
| Molecular Weight | 395.86 |
| Pharmacopoeia | IN HOUSE |
| Packaging | 25 KG/DRUM |
Enrofloxacin Hydrochloride is the hydrochloride salt of enrofloxacin, a fluoroquinolone antibiotic developed specifically for veterinary use. As the HCl salt form, it offers enhanced water solubility compared to the base form, making it particularly suitable for oral solution and drinking water formulations. It exerts its bactericidal effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication.
Enrofloxacin HCl demonstrates broad-spectrum bactericidal activity against both Gram-negative bacteria (including E. coli, Salmonella, Pasteurella, and Actinobacillus) and Gram-positive bacteria, as well as against Mycoplasma species and intracellular pathogens such as Brucella and Chlamydia. Its excellent bioavailability and extensive tissue penetration allow it to reach therapeutic concentrations in the respiratory tract, urinary tract, gastrointestinal tract, and skin. It is partially metabolized to ciprofloxacin in vivo, contributing to its sustained antimicrobial effect.
| Purity | As per IN HOUSE standard |
|---|---|
| Water Content | Controlled per specification |
| Heavy Metals | Compliant with pharmacopoeia limits |
| GMP Status | Manufactured under GMP conditions |
Administered via drinking water for treatment of colibacillosis, fowl cholera, chronic respiratory disease, and mycoplasmosis in broilers and layers.
Treatment of skin and soft tissue infections, urinary tract infections, and respiratory infections in dogs and cats. Excellent bioavailability after oral administration.